Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David F Ransohoff

Showing results (21-30 of 102) with videos related to

Pageof 11
Sort By:
Lancet (London, England)|May 1, 2010
Can endoscopy protect against colorectal cancer? An RCTDavid F Ransohoff
Nature Reviews. Cancer|February 3, 2005
Bias as a threat to the validity of cancer molecular-marker researchDavid F Ransohoff
Gastroenterology|May 12, 2005
Colon cancer screening in 2005: status and challengesDavid F Ransohoff
Lancet (London, England)|April 20, 2002
Lessons from the UK sigmoidoscopy screening trialDavid F Ransohoff
Clinical Chemistry|December 31, 2009
Proteomics research to discover markers: what can we learn from Netflix?David F Ransohoff
The Lancet. Oncology|February 25, 2014
What is the effect of more sensitive diagnostic technology?David F Ransohoff
Science (New York, N.Y.)|March 15, 2003
Cancer. Developing molecular biomarkers for cancerDavid F Ransohoff
Medical Decision Making : an International Journal of the Society for Medical Decision Making|July 16, 2011
Cross-model comparisons to improve the value of modeling: the case of colorectal cancer screeningMichael Pignone, David F Ransohoff
JAMA|April 19, 2002
Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific reviewNicholas Shaheen, David F Ransohoff
JAMA|April 19, 2002
Gastroesophageal reflux, Barrett esophagus, and esophageal cancer: clinical applicationsNicholas Shaheen, David F Ransohoff
Pageof 11

Showing results (21-30 of 102) with videos related to

Sort By:
Pageof 11
Lancet (London, England)|May 1, 2010
Can endoscopy protect against colorectal cancer? An RCTDavid F Ransohoff
Nature Reviews. Cancer|February 3, 2005
Bias as a threat to the validity of cancer molecular-marker researchDavid F Ransohoff
Gastroenterology|May 12, 2005
Colon cancer screening in 2005: status and challengesDavid F Ransohoff
Lancet (London, England)|April 20, 2002
Lessons from the UK sigmoidoscopy screening trialDavid F Ransohoff
Clinical Chemistry|December 31, 2009
Proteomics research to discover markers: what can we learn from Netflix?David F Ransohoff
The Lancet. Oncology|February 25, 2014
What is the effect of more sensitive diagnostic technology?David F Ransohoff
Science (New York, N.Y.)|March 15, 2003
Cancer. Developing molecular biomarkers for cancerDavid F Ransohoff
Medical Decision Making : an International Journal of the Society for Medical Decision Making|July 16, 2011
Cross-model comparisons to improve the value of modeling: the case of colorectal cancer screeningMichael Pignone, David F Ransohoff
JAMA|April 19, 2002
Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific reviewNicholas Shaheen, David F Ransohoff
JAMA|April 19, 2002
Gastroesophageal reflux, Barrett esophagus, and esophageal cancer: clinical applicationsNicholas Shaheen, David F Ransohoff
Pageof 11